Radiogenomics: Hunting Down Liver Metastasis in Colorectal Cancer Patients

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2021 Nov 13

PMID 34771709

Citations 15

Authors

Carolina De la Pinta

Maria E Castillo

Manuel Collado

Cristina Galindo-Pumarino

Cristina Pena

Affiliations

Soon will be listed here.

Abstract

Radiomics is a developing new discipline that analyzes conventional medical images to extract quantifiable data that can be mined for new biomarkers that show the biology of pathological processes at microscopic levels. These data can be converted into image-based signatures to improve diagnostic, prognostic and predictive accuracy in cancer patients. The combination of radiomics and molecular data, called radiogenomics, has clear implications for cancer patients' management. Though some studies have focused on radiogenomics signatures in hepatocellular carcinoma patients, only a few have examined colorectal cancer metastatic lesions in the liver. Moreover, the need to differentiate between liver lesions is fundamental for accurate diagnosis and treatment. In this review, we summarize the knowledge gained from radiomics and radiogenomics studies in hepatic metastatic colorectal cancer patients and their use in early diagnosis, response assessment and treatment decisions. We also investigate their value as possible prognostic biomarkers. In addition, the great potential of image mining to provide a comprehensive view of liver niche formation is examined thoroughly. Finally, new challenges and current limitations for the early detection of the liver premetastatic niche, based on radiomics and radiogenomics, are also discussed.

Citing Articles

Image Analysis as tool for Predicting Colorectal Cancer Molecular Alterations: A Scoping Review.

Mohammadpour S, Emami H, Rabiei R, Hosseini A, Moghaddasi H, Faeghi F Mol Imaging Radionucl Ther. 2025; 34(1):10-25.

PMID: 39917985 PMC: 11827529. DOI: 10.4274/mirt.galenos.2024.86402.

Rapid detection of liver metastasis risk in colorectal cancer patients through blood test indicators.

Yu Z, Li G, Xu W Front Oncol. 2024; 14:1460136.

PMID: 39324006 PMC: 11422013. DOI: 10.3389/fonc.2024.1460136.

A study predicting long-term survival capacity in postoperative advanced gastric cancer patients based on MAOA and subcutaneous muscle fat characteristics.

Han Y, Chang Y, Wang J, Li N, Yu Y, Yang Z World J Surg Oncol. 2024; 22(1):184.

PMID: 39010072 PMC: 11251287. DOI: 10.1186/s12957-024-03466-7.

AI-driven estimation of O6 methylguanine-DNA-methyltransferase (MGMT) promoter methylation in glioblastoma patients: a systematic review with bias analysis.

Samartha M, Dubey N, Jena B, Maheswar G, Lo W, Saxena S J Cancer Res Clin Oncol. 2024; 150(2):57.

PMID: 38291266 PMC: 10827977. DOI: 10.1007/s00432-023-05566-5.

Radiomics and Radiogenomics in Pelvic Oncology: Current Applications and Future Directions.

OSullivan N, Kelly M Curr Oncol. 2023; 30(5):4936-4945.

PMID: 37232830 PMC: 10217419. DOI: 10.3390/curroncol30050372.

References

Starosolski Z, Courtney A, Srivastava M, Guo L, Stupin I, Metelitsa L . A Nanoradiomics Approach for Differentiation of Tumors Based on Tumor-Associated Macrophage Burden. Contrast Media Mol Imaging. 2021; 2021:6641384. PMC: 8216795. DOI: 10.1155/2021/6641384. View

Wagner H, Toth C, Steele Jr G, Thomas P . Metastatic potential of human colon cancer cell lines: relationship to cellular differentiation and carcinoembryonic antigen production. Clin Exp Metastasis. 1992; 10(1):25-31. DOI: 10.1007/BF00163573. View

Creasy J, Cunanan K, Chakraborty J, McAuliffe J, Chou J, Gonen M . Differences in Liver Parenchyma are Measurable with CT Radiomics at Initial Colon Resection in Patients that Develop Hepatic Metastases from Stage II/III Colon Cancer. Ann Surg Oncol. 2020; 28(4):1982-1989. PMC: 7940539. DOI: 10.1245/s10434-020-09134-w. View

Dohan A, Gallix B, Guiu B, Le Malicot K, Reinhold C, Soyer P . Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumab. Gut. 2019; 69(3):531-539. DOI: 10.1136/gutjnl-2018-316407. View

Smedley N, Aberle D, Hsu W . Using deep neural networks and interpretability methods to identify gene expression patterns that predict radiomic features and histology in non-small cell lung cancer. J Med Imaging (Bellingham). 2021; 8(3):031906. PMC: 8105647. DOI: 10.1117/1.JMI.8.3.031906. View

Lee J, Lee K, Seo B, Cho K, Woo O, Song S . Radiomic machine learning for predicting prognostic biomarkers and molecular subtypes of breast cancer using tumor heterogeneity and angiogenesis properties on MRI. Eur Radiol. 2021; 32(1):650-660. DOI: 10.1007/s00330-021-08146-8. View

Xiao J, Rahbar H, Hippe D, Rendi M, Parker E, Shekar N . Dynamic contrast-enhanced breast MRI features correlate with invasive breast cancer angiogenesis. NPJ Breast Cancer. 2021; 7(1):42. PMC: 8052427. DOI: 10.1038/s41523-021-00247-3. View

Reimer R, Reimer P, Mahnken A . Assessment of Therapy Response to Transarterial Radioembolization for Liver Metastases by Means of Post-treatment MRI-Based Texture Analysis. Cardiovasc Intervent Radiol. 2018; 41(10):1545-1556. DOI: 10.1007/s00270-018-2004-2. View

Ganeshan B, Miles K, Young R, Chatwin C . Hepatic enhancement in colorectal cancer: texture analysis correlates with hepatic hemodynamics and patient survival. Acad Radiol. 2007; 14(12):1520-30. DOI: 10.1016/j.acra.2007.06.028. View

10.

Rudmik L, Magliocco A . Molecular mechanisms of hepatic metastasis in colorectal cancer. J Surg Oncol. 2005; 92(4):347-59. DOI: 10.1002/jso.20393. View

11.

Rizzetto F, Calderoni F, De Mattia C, Defeudis A, Giannini V, Mazzetti S . Impact of inter-reader contouring variability on textural radiomics of colorectal liver metastases. Eur Radiol Exp. 2020; 4(1):62. PMC: 7652946. DOI: 10.1186/s41747-020-00189-8. View

12.

Jeon S, Lim Y, Koh J, Chang W, Kim S, Kim K . A radiomic signature model to predict the chemoradiation-induced alteration in tumor-infiltrating CD8 cells in locally advanced rectal cancer. Radiother Oncol. 2021; 162:124-131. DOI: 10.1016/j.radonc.2021.07.004. View

13.

Yin Q, Hung S, Wang L, Lin W, Fielding J, Rathmell W . Associations between Tumor Vascularity, Vascular Endothelial Growth Factor Expression and PET/MRI Radiomic Signatures in Primary Clear-Cell-Renal-Cell-Carcinoma: Proof-of-Concept Study. Sci Rep. 2017; 7:43356. PMC: 5335708. DOI: 10.1038/srep43356. View

14.

Di Martino M, Rompianesi G, Mora-Guzman I, Martin-Perez E, Montalti R, Troisi R . Systematic review and meta-analysis of local ablative therapies for resectable colorectal liver metastases. Eur J Surg Oncol. 2019; 46(5):772-781. DOI: 10.1016/j.ejso.2019.12.003. View

15.

Rao S, Lambregts D, Schnerr R, Ommen W, van Nijnatten T, Martens M . Whole-liver CT texture analysis in colorectal cancer: Does the presence of liver metastases affect the texture of the remaining liver?. United European Gastroenterol J. 2014; 2(6):530-8. PMC: 4245301. DOI: 10.1177/2050640614552463. View

16.

Engstrand J, Nilsson H, Stromberg C, Jonas E, Freedman J . Colorectal cancer liver metastases - a population-based study on incidence, management and survival. BMC Cancer. 2018; 18(1):78. PMC: 5769309. DOI: 10.1186/s12885-017-3925-x. View

17.

Liu P, Tan X, Zhang T, Gu Q, Mao X, Li Y . Prediction of microvascular invasion in solitary hepatocellular carcinoma ≤ 5 cm based on computed tomography radiomics. World J Gastroenterol. 2021; 27(17):2015-2024. PMC: 8108034. DOI: 10.3748/wjg.v27.i17.2015. View

18.

Langley R, Fidler I . The seed and soil hypothesis revisited--the role of tumor-stroma interactions in metastasis to different organs. Int J Cancer. 2011; 128(11):2527-35. PMC: 3075088. DOI: 10.1002/ijc.26031. View

19.

Taghavi M, Trebeschi S, Simoes R, Meek D, Beckers R, Lambregts D . Machine learning-based analysis of CT radiomics model for prediction of colorectal metachronous liver metastases. Abdom Radiol (NY). 2020; 46(1):249-256. DOI: 10.1007/s00261-020-02624-1. View

20.

Siveen K, Raza A, Ahmed E, Khan A, Prabhu K, Kuttikrishnan S . The Role of Extracellular Vesicles as Modulators of the Tumor Microenvironment, Metastasis and Drug Resistance in Colorectal Cancer. Cancers (Basel). 2019; 11(6). PMC: 6628238. DOI: 10.3390/cancers11060746. View